According to the prediction of Yan et al., Cyclin D1 was also a target of Erianin in the treatment of lung cancer, cervical cancer, bladder cancer, colorectal cancer and breast cancer [21]. This evidence concerns the gene CCND1 and urinary bladder carcinoma.